Autopsy report · NCT05423197

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

“logistical issues”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Andrei Iagaru

Sponsor type

University, hospital or other

Conditions

Head-and-neck Squamous Cell Carcinoma

Interventions

89Zr-panitumumab IV; Panitumumab

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Host-microbiota-environment Interactions
  “logistical difficulties” (91% match in meaning)
• Use of ICON™ to Detect Hemodynamic Variables During Dexmedetomidine Sedation in Children Undergoing Pulmonary Function Test
  “logistical challenges” (87% match in meaning)
• SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty
  “Logistical constraints” (78% match in meaning)
• Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation
  “Lack of funding and other logistical issues” (74% match in meaning)
• Influence of PESF on Oxygen Saturation, Quality of Life and Exercise Capacity in COPD
  “Logistical problems at study site” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.